Gene · 122876
GPHB5: glycoprotein hormone subunit beta 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GPHB5: glycoprotein hormone subunit beta 5. Genes, record 122876. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/122876
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q86YW7 | Glycoprotein hormone beta-5 | 130 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents48
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 18381 | Q86YW7 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 3679 | Q86YW7 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 22847 | Q86YW7 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 6147 | Q86YW7 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 6148 | Q86YW7 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 3679 | Q86YW7 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 22847 | Q86YW7 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18381 | Q86YW7 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 6147 | Q86YW7 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 6148 | Q86YW7 | Espacenet |
1 to 10 of 48
See all 48 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,991
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GPHB5 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 11 | 2025 |
| R01AI143714 | Selective Plasmodium proteasome inhibitors as novel multi-stage antimalarials | 9 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA056036 | Translational Research in Cancer | 6 | 2025 |
| ZIABC010440 | Protein Structure, Stability, and Amyloid Formation | 6 | 2025 |
| ZIABC010441 | Biomolecular Recognition and Binding Mechanisms | 5 | 2025 |
| P30CA013148 | Comprehensive Cancer Center Support Grant | 4 | 2025 |
| P30CA023168 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,991Source NIH's project files
See all 1,991 nih grantsPapers2,598
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct tubulin C-terminal tails control the efficiency of a microtubule severing machine. | J Chem Phys | 2026 | 42746985 | PubTator, text mining | PubMed |
| Glycoprotein hormone GPA2/GPB5: discoveries and insights from invertebrates. | Gen Comp Endocrinol | 2026 | 42727788 | PubTator, text mining | PubMed |
| Proteasome Dysfunction in Basal Keratinocytes Drives Epidermal Disruption and Dermal Inflammation. | Am J Pathol | 2026 | 42674183 | PubTator, text mining | PubMed |
| Controlling lignin nanoparticle morphology and properties via tailoring molecular weight and interunit linkage from biorefinery residues. | Int J Biol Macromol | 2026 | 42503379 | PubTator, text mining | PubMed |
| Composition and activity of the proteasome in human iPSC-derived neuronal model of early-stage sporadic Alzheimer's disease. | bioRxiv | 2026 | 42395371 | PubTator, text mining | PubMed |
| Pyran-core small molecules inhibit basal-like triple-negative breast cancer via proteasome activity. | Future Med Chem | 2026 | 42273772 | PubTator, text mining | PubMed |
| Initial Stage of Guaiacyl-Syringyl Lignin Formation from Coniferyl and Sinapyl Alcohols. | J Agric Food Chem | 2026 | 42261739 | PubTator, text mining | PubMed |
| Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma. | Cells | 2026 | 42193875 | PubTator, text mining | PubMed |
| Antioxidant functionalization of pullulan with ferulic acid using enzymatic catalysis. | Carbohydr Polym | 2026 | 41943309 | PubTator, text mining | PubMed |
| USP10 deubiquitinase: Physiological function, diseases and therapeutic target (Review). | Int J Mol Med | 2026 | 41891958 | PubTator, text mining | PubMed |
1 to 10 of 2,598
See all 2,598 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/122876
GET https://conductscience.org/api/genes/v1/122876/patents?page=2